Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000800281 | SCV000939986 | uncertain significance | Fanconi anemia | 2020-08-15 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs752962214, ExAC 0.02%). This sequence change replaces tyrosine with cysteine at codon 968 of the FANCM protein (p.Tyr968Cys). The tyrosine residue is weakly conserved and there is a large physicochemical difference between tyrosine and cysteine. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The cysteine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with FANCM-related disease. |
Gene |
RCV003235402 | SCV003933547 | uncertain significance | not provided | 2024-07-09 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis indicates that this missense variant does not alter protein structure/function; Observed in the germline of an individual with acute lymphoblastic leukemia undergoing whole exome sequencing (PMID: 35739278); This variant is associated with the following publications: (PMID: 35739278) |